Psychiatric deprescribing is gaining national attention as policymakers call for closer scrutiny of psychiatric prescribing and greater use of nonmedication supports. But reducing or stopping a psychiatric medication is rarely simple: it requires careful monitoring, individualized planning and ongoing support to manage potential discontinuation symptoms.
Joining BHB’s Ashleigh Hollowell on the BHB Perspectives podcast is Dr. Anita Clayton, a UVA Health psychiatrist and co-author of new national antidepressant deprescribing recommendations. Clayton discusses UVA Health’s recently launched psychiatric deprescribing clinic, its role in training future psychiatrists and the practical challenges.
Tune in now!
The fourth episode of the Behavioral Health Business Perspectives podcast is now live! Behavioral Health Business Editor Laura Lovett sits down with Corbin Petro,...
The newest episode of the Behavioral Health Business Perspectives podcast is out! In this episode, BHB sits down with Dr. Diego Garza, who serves...
Early this year, 2,400 clinicians at Kaiser Permanente made history: they delivered the behavioral health sector’s first-ever union strike over AI, protesting their concerns...